Credit Suisse’s Enzo Biochem, Inc. ENZ Stock Holding History

Credit Suisse’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-12,664	Closed	-$32K	–	4616
2020 Q4	$32K	Sell	12,664 -254	-2%	-$553	﹤0.01%	4282
2020 Q3	$28K	Buy	+12,918	New	+$30.7K	﹤0.01%	3978
2019 Q4	–	Sell	-13,672	Closed	-$49K	–	4368
2019 Q3	$49K	Sell	13,672 -1,120	-8%	-$3.96K	﹤0.01%	4035
2019 Q2	$50K	Buy	14,792 +4,663	+46%	+$16.4K	﹤0.01%	4000
2019 Q1	$27K	Buy	+10,129	New	+$33.2K	﹤0.01%	3931
2018 Q3	–	Sell	-12,887	Closed	-$66K	–	4037
2018 Q2	$66K	Sell	12,887 -12,470	-49%	-$76K	﹤0.01%	3874
2018 Q1	$139K	Buy	25,357 +11,936	+89%	+$84.1K	﹤0.01%	3759
2017 Q4	$110K	Sell	13,421 -18,521	-58%	-$177K	﹤0.01%	3829
2017 Q3	$334K	Buy	+31,942	New	+$355K	﹤0.01%	3692
2017 Q1	–	Sell	-28,192	Closed	-$196K	–	4116
2016 Q4	$196K	Buy	28,192 +12,416	+79%	+$79.2K	﹤0.01%	3820
2016 Q3	$80K	Sell	15,776 -2,297	-13%	-$13.7K	﹤0.01%	3959
2016 Q2	$108K	Sell	18,073 -72,876	-80%	-$404K	﹤0.01%	4043
2016 Q1	$414K	Buy	90,949 +58,980	+184%	+$263K	﹤0.01%	3354
2015 Q4	$144K	Buy	+31,969	New	+$135K	﹤0.01%	4005
2015 Q3	–	Sell	-46,845	Closed	-$142K	–	4520
2015 Q2	$142K	Buy	+46,845	New	+$132K	﹤0.01%	4320
2015 Q1	–	Sell	-17,131	Closed	-$76K	–	4618
2014 Q4	$76K	Sell	17,131 -15,747	-48%	-$75.1K	﹤0.01%	4480
2014 Q3	$169K	Sell	32,878 -9,441	-22%	-$50.4K	﹤0.01%	4186
2014 Q2	$222K	Buy	+42,319	New	+$183K	﹤0.01%	4288
2013 Q3	–	Sell	-24,055	Closed	-$50K	–	4401
2013 Q2	$50K	Buy	+24,055	New	+$53.1K	﹤0.01%	4099

Other funds holding ENZ

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Credit Suisse's ENZ Position: Q1 2021 in Review

Credit Suisse sold out of Enzo Biochem, Inc. (ENZ) in Q1 2021, closing a stake of 12,664 shares — an estimated $32K sold.

Credit Suisse first reported a position in ENZ in Q2 2013 and held it in 19 quarters. The position peaked at $414K in Q1 2016. 82 funds tracked by Wall St. Rank hold ENZ as of Q1 2021.

Credit Suisse reported no remaining Enzo Biochem, Inc. position as of Q1 2021 after selling out during the quarter.
Credit Suisse sold 12,664 Enzo Biochem, Inc. shares in Q1 2021, an estimated $32K.
Credit Suisse first reported a position in Enzo Biochem, Inc. in Q2 2013 and held it in 19 quarters.
Credit Suisse's Enzo Biochem, Inc. position peaked at $414K in Q1 2016.
82 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2021.

Based on Credit Suisse's 13F filing for Q1 2021, filed 14 May 2021.